Next Article in Journal
Current Overview of Metal Nanoparticles’ Synthesis, Characterization, and Biomedical Applications, with a Focus on Silver and Gold Nanoparticles
Next Article in Special Issue
Pharmacological Nature of the Purinergic P2Y Receptor Subtypes That Participate in the Blood Pressure Changes Produced by ADPβS in Rats
Previous Article in Journal
Methyleugenol Has an Antidepressant Effect in a Neuroendocrine Model: In Silico and In Vivo Evidence
Previous Article in Special Issue
Nonselective and A2a-Selective Inhibition of Adenosine Receptors Modulates Renal Perfusion and Excretion Depending on the Duration of Streptozotocin-Induced Diabetes in Rats
 
 
Article
Peer-Review Record

Endothelial Effects of Simultaneous Expression of Human HO-1, E5NT, and ENTPD1 in a Mouse

Pharmaceuticals 2023, 16(10), 1409; https://doi.org/10.3390/ph16101409
by Paulina Mierzejewska 1, Noemi Di Marzo 2, Magdalena A. Zabielska-Kaczorowska 1,3, Iga Walczak 1, Ewa M. Slominska 1, Marialuisa Lavitrano 2, Roberto Giovannoni 2,4, Barbara Kutryb-Zajac 1,* and Ryszard T. Smolenski 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Pharmaceuticals 2023, 16(10), 1409; https://doi.org/10.3390/ph16101409
Submission received: 1 September 2023 / Revised: 26 September 2023 / Accepted: 28 September 2023 / Published: 4 October 2023
(This article belongs to the Special Issue Adenosine Metabolism-Key Targets in Cardiovascular Pharmacology)

Round 1

Reviewer 1 Report

The authors submitted the paper entitled “Endothelial effects of simultaneous expression of human HO-1, E5NT, and ENTPD1 in a mouse” starting from the fundamental argument that vascular endothelium is key target for immune and thrombotic responses that has to be controlled in successful xenotransplantation. The aim was to evaluate in vivo the effects of the simultaneous expression of a three human genes in a mouse generated using the multi-cistronic F2A technology. The obtained results suggested that the human enzymes (hHO-1, hE5NT, hENTPD1), simultaneously encoded in transgenic mice, demonstrated benefits in several biochemical and functional aspects of endothelium, which would be consistent in use of this approach in the context of xenotransplantation.

The paper was very well prepared with exhaustive and scientifically sound introduction, appropriately chosen and executed methodology, as well as high-level-quality discussion adequately comparing so far knowledge of other scientists with the obtained results. Although experimental in nature, this paper presents full clinical relevance, yet to be fully investigated.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

The authors of this manuscript investigated the effects of the simultaneous expression of three human genes, heme oxygenase 1 (hHO-1), ecto-5'-nucleotidase (hE5NT), and ecto-nucleoside tri-18 phosphate diphosphohydrolase 1 (hENTPD1), in a mouse. The results prove the anti-inflammatory and protective effects of this combination of human genes. It is concluded that genetic modification may be beneficial to preserve endothelial function in the context of xenotransplantation.

The article can be published after some corrections.

1.           The authors use parametric methods for statistical processing of the results. This is acceptable if the data are normally distributed. Was a test for "normality" performed?

2.           Methods section, ELISA reagents. "RAB0477" should be removed; this is a kit for the analysis of TNF, and it was not measured in this work.

3. The authors write

"There was a tendency to higher L-arginine concentration and decrease in its analogues - asymmetric dimethyl L-arginine (ADMA) and L-NG-monomethyl arginine (L-NMMA) in transgenic mice as compared to control". In Table 1 for L-NMMA level p is less than 0.05. Formally, this is not a tendency, but a significant difference.

4.           The number of animals in the groups should be indicated in the captions to Figs. 3 and 4. For uniformity, the colour of the bars should be black and white.

 

5.           Replace IFN-Y (line 204) with INF-gamma.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop